Example Output: Healthcare Life Science Experiment Launch Plan
Inputs used
- Project context: a clinic operations assistant that summarizes appointment preparation tasks
- Target audience: clinical operations, life science teams, patient experience, health tech PMs
- Success metric: activation, quality, and risk reduction
- Available tools and data: SOP repository, EHR export with safeguards, quality dashboard, review queue
- Desired depth: Production-ready
- Output tone: Clear operator memo
Generated Result
hypothesis, audience, variants, instrumentation, and decision rule
Hypothesis
Hypothesis: improving how the workflow handles workflow SOPs will reduce clinical overreach. Ship two variants at most, instrument the primary metric before launch, and decide in advance what evidence stops the test.
Target segment
Use de-identified notes as evidence, apply the constraint "use de-identified data", and explicitly note how the plan reduces PHI exposure. The output should be ready for a practitioner to act on without a follow-up explanation.
Variants
Hypothesis: improving how the workflow handles protocol excerpts will reduce protocol misinterpretation. Ship two variants at most, instrument the primary metric before launch, and decide in advance what evidence stops the test.
Instrumentation
Hypothesis: improving how the workflow handles quality metrics will reduce equity blind spots. Ship two variants at most, instrument the primary metric before launch, and decide in advance what evidence stops the test.
Risks
Treat clinical overreach as a launch blocker until there is a control that can be verified. The minimum control is: use de-identified data, plus reviewer sign-off for ambiguous outputs.
Decision rule
Hypothesis: improving how the workflow handles de-identified notes will reduce PHI exposure. Ship two variants at most, instrument the primary metric before launch, and decide in advance what evidence stops the test.
Recommended Decision
Proceed with a narrow pilot focused on workflow SOPs and de-identified notes. Treat clinical overreach as the primary launch blocker. The first milestone should prove that the workflow produces a usable safe workflow brief, escalation rules, and audit checklist with clear evidence, named owners, and a review path for ambiguous cases.
Expected quality checks
- The result is specific to AI-assisted patient ops, protocol comprehension, life science research support, and quality review.
- It includes the required sections: Hypothesis, Target segment, Variants, Instrumentation, Risks, Decision rule.
- It separates evidence, assumptions, risks, and recommended next actions.
- It includes practical verification steps, not only generic advice.
- It names the most important failure mode for this domain: clinical overreach.
Reuse note
Before copying the output into production work, replace all default variables with your real data and run a human review for high-impact decisions.